Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal fentanyl and pruritus in opium-dependent patients undergoing lower limb orthopedic surgery
IRCT20231223060498N1Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fentanyl and bupivacaine in opioid use disorder (OUD) (2 arms), sponsored by Golestan University of Medical Sciences. Primary endpoints: Prevalence of pruritus and Intensity of pruritus. Started Feb 2024; status: completed.
02
Drugs
fentanylbupivacaine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT20231223060498N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231223060498N1.